Curious to see your top suppliers emissions?
Book a demo for a pilot project
Book a demo for a pilot project
Arcxis Biotechnologies, Inc., a leading name in the biotechnology sector, is headquartered in the United States and operates across key regions globally. Founded in [year], the company has made significant strides in advancing biopharmaceutical solutions, focusing on innovative drug delivery systems and cutting-edge therapeutic technologies.
Specialising in the development of proprietary platforms, Arcxis Biotechnologies offers unique products that enhance the efficacy and safety of treatments. Their commitment to research and development has positioned them as a notable player in the industry, recognised for their contributions to improving patient outcomes.
With a strong market presence, Arcxis Biotechnologies continues to push the boundaries of biotechnology, striving to meet the evolving needs of healthcare providers and patients alike. Their dedication to excellence and innovation sets them apart in a competitive landscape.
+49 vs industry average
Arcxis Biotechnologies, Inc.’s score of 59 is lower than 42% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Food Waste Composting is among the most carbon-intensive industries
The Food Waste Composting industry has reduced its overall emissions by 39% since 2018
No reported emissions data is available for Arcxis Biotechnologies, Inc. yet.
Arcxis Biotechnologies, Inc., headquartered in the US, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Standard BioTools Inc., which may influence its climate commitments and emissions reporting.
As of now, Arcxis Biotechnologies has not established any documented reduction targets or initiatives related to the Science Based Targets initiative (SBTi). Additionally, there are no climate pledges or significant reduction achievements reported.
Given the absence of direct emissions data, it is important to note that the company may be aligned with broader industry standards and practices, particularly those set by its parent company, Standard BioTools Inc. However, without specific figures or commitments, the details of their climate strategy remain vague.
In summary, while Arcxis Biotechnologies, Inc. is part of a corporate family that may have climate initiatives, it currently lacks publicly available emissions data and defined reduction targets.
Access structured emission data, company specific factors and auditable source documents
No climate goals have been disclosed for Arcxis Biotechnologies, Inc. yet.
No scope 3 category breakdown has been disclosed yet.


No peer comparison is available for Arcxis Biotechnologies, Inc. yet.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more